Innocoll, Inc. announced that its wholly-owned subsidiary, Innocoll Pharmaceuticals, has filed a US 510k application for CollaGUARD™, an advanced wound care product based on Innocoll's proprietary CollaRx™ membrane technology. More
Palau Pharma today announces that its partner, Iberhospitex S.A. ("IHT"), has received marketing approval from the Spanish Agency for Medicines and Medical devices for its ACTIVE® coronary stent. More
Zambon will license Vectura's PowderHale(tm) pulmonary formulation technology for the development and commercialisation of a new dry powder inhaler product. More
Innocoll, Inc. announced its sales and marketing subsidiary, Innocoll Pharmaceuticals Ltd., has launched a new version of its CollaRx Gentamicin Surgical Implant that is specially designed for maximum convenience and ease of use in cardiac surgery. More
The world's first robotically-assisted intestinal bypass surgery for a patient with superior mesenteric artery syndrome (SMA), also known as Wilkie's syndrome, was performed at University Hospital on July 30, 2008. More
The Lindros Legacy Research Building at University Hospital will soon house another state-of-the-art facility - the Kelman Centre for Advanced Learning at CSTAR. More
All rights reserved. Terms and Conditions | Contact us
